One issue that often is overlooked is the importance of sexual intimacy. It may be surprising to know that approximately 40 million American women suffer from some type of sexual disorder — the most common being Hypoactive Sexual Desire Disorder (HSDD), sometimes referred to as low sex drive.
BioSante Pharmaceuticals, Inc. is currently sponsoring a nationwide medical research study, the Bloom Study, to determine if LibiGel®, an investigational study medication, can increase women’s sexual desire.
“We know there is a tremendous medical need to address women suffering with low sexual desire,” said James A. Simon, MD, a LibiGel study investigator, clinical professor of Obstetrics and Gynecology at the George Washington University in Washington, DC, medical director at The Women’s Health Research Center in Laurel, Maryland and past president of the North American Menopause Society. “Currently, there are no medications approved by the US Food and Drug Administration (FDA) for the treatment of low sexual desire.”
Sexual activity has many health benefits and is an important part of relationships. But those with HSDD are rarely in the mood for intimacy. For women who have gone through menopause either naturally or after surgery, a decrease in the production of natural testosterone may occur. Testosterone is a hormone that affects many things, including sex drive. The reduction in testosterone may contribute to the symptoms of HSDD, a common condition defined as the persistent lack of sexual desire. And this decrease in sex drive can result in personal distress and interpersonal problems.
The Bloom Study is currently looking for Brooklyn area women at least 30 years of age who have lost their sex drive. Qualified participants must have either gone through menopause or had their ovaries removed. The study is examining the safety and effectiveness of the investigational medication, LibiGel, for the treatment of HSDD. The investigational medication is applied daily to the skin on a woman’s upper arm.
The Bloom Study is taking place in Brooklyn and other cities across the United States. For more on the Bloom Study, visit www.bloomstudy.com or call 1-877-BLOOM-81.
©2008 Community News Group
By submitting this comment, you agree to the following terms:
You agree that you, and not BrooklynDaily.com or its affiliates, are fully responsible for the content that you post. You agree not to post any abusive, obscene, vulgar, slanderous, hateful, threatening or sexually-oriented material or any material that may violate applicable law; doing so may lead to the removal of your post and to your being permanently banned from posting to the site. You grant to BrooklynDaily.com the royalty-free, irrevocable, perpetual and fully sublicensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part world-wide and to incorporate it in other works in any form, media or technology now known or later developed.